6.Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. 1971. Milbank Q 2005;83:731-57.
8.National Cancer Center. Cancer registry system in Korea. Korea Central Cancer Registry [Internet]. Goyang (Korea): National Cancer Center; [cited 2023 Dec 20]. Available from:
http://www.ncc.re.kr.
9.Korean Statistical Information System. National Statistical Office, Korea [Internet]. Daejeon (Korea): Statistics Korea; [cited 2023 Dec 20]. Available from:
http://kosis.nso.go.kr.
10.Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Par-kin DM, editors. International classification of disease for oncology. 3rd ed. Geneva (Switzerland): World Health Organization; 2000.
11.Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol 2012;61:1079-92.
12.Kvale R, Auvinen A, Adami HO, Klint A, Hernes E, Moller B, et al. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst 2007;99:1881-7.
14.Bray F, Pineros M. Cancer patterns, trends and projections in Latin America and the Caribbean: a global context. Salud Publica Mex 2016;58:104-17.
15.Wong MC, Goggins WB, Wang HH, Fung FD, Leung C, Wong SY, et al. Global incidence and mortality for prostate cancer: analysis of temporal patterns and trends in 36 countries. Eur Urol 2016;70:862-74.
17.Tsodikov A, Gulati R, Etzioni R. Reconciling the effects of screening on prostate cancer mortality in the ERSPC and PLCO trials. Ann Intern Med 2018;168:608-9.
18.Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 2017;71:96-108.
19.Teoh JY, Huang J, Ko WY, Lok V, Choi P, Ng CF, et al. Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita. Eur Urol 2020;78:893-906.